Translational and developmental perspective on N-methyl-D-aspartate synaptic deficits in schizophrenia

Development and Psychopathology

Volumn 18, Issue 3, 2006, Pages 853-876

  MacDonald III, Angus W ^a   Chafee, Matthew V ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO AMINO ACID OXIDASE; DYSTROBREVIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KETAMINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; PHENCYCLIDINE; RGS PROTEIN;

AGITATION; ARTICLE; BRAIN DYSFUNCTION; CATATONIA; COGNITION; CONSENSUS; DRUG ABUSE; GENETIC POLYMORPHISM; HALLUCINATION; HUMAN; MEDICAL RESEARCH; MEMORY DISORDER; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PARANOIA; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; SYMPTOM; SYNAPTIC TRANSMISSION;

CARRIER PROTEINS; COGNITION DISORDERS; HUMANS; INTERDISCIPLINARY COMMUNICATION; N-METHYLASPARTATE; NERVE NET; NERVE TISSUE PROTEINS; NEUREGULIN-1; NEURONAL PLASTICITY; PREFRONTAL CORTEX; PRESYNAPTIC TERMINALS; PSYCHOLOGICAL THEORY; RECEPTORS, METABOTROPIC GLUTAMATE; RGS PROTEINS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR;

EID: 33748998496     PISSN: 09545794     EISSN: 14692198     Source Type: Journal    
DOI: 10.1017/S0954579406060421     Document Type: Article

References (116)

1. Adler, C. M., Goldberg, T. E., Malhotra, A. K., Pickar, D., & Breier, A. (1998). Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biological Psychiatry, 43, 811-816.
2. Andreasen, N. C., Rezai, K., Alliger, R., Swayze, V., Flaum, M., Kirchner, P., et al. (1992). Hypofrontality in neuroleptic naive patients and in patients with chronic schizophrenia: Assessment with xenon 133 single photon emission computed tomography and the tower of london. Archives of General Psychiatry, 49, 943-958.
3. Arndt, S., Alliger, R. J., & Andreasen, N. C. (1991). The distinction of positive and negative symptoms: The failure of the two dimensional model. British Journal of Psychiatry, 158, 46-50.
4. Baddeley, A. D., & Hitch, G. J. (1974). Working memory. In G. Bower (Ed.), The psychology of learning and motivation (Vol. 8, pp. 47-90). San Diego, CA: Academic Press.
5. Barch, D., Carter, C., MacDonald, A., Braver, T., & Cohen, J. (2003). Context processing deficits in schizophrenia: Diagnostic specificity, four-week course, and relationships to clinical symptoms. Journal of Abnormal Psychology, 112, 132-143.
6. Barch, D. M., Braver, T. S., Nystrom, L. E., Forman, S. D., Noll, D. C., & Cohen, J. D. (1997). Dissociating working memory from task difficulty in human prefrontal cortex. Neuropsychologia, 35, 1373-1380.
7. Barch, D. M., Carter, C. S., Braver, T. S., Sabb, F. W., MacDonald, A. III, Noll, D. C., et al. (2001). Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Archives of General Psychiatry, 58, 280-288.
8. Becker, T. M., Snitz, B. E., Kerns, J. G., Barch, D. M., Yablonsky, E. J., Holmes, A., et al. (2003). Context processing deficits and associated hypofrontality predict functional outcome in first episode schizophrenia patients. Paper presented at the Society for Neuroscience.
9. Benes, F. M., & Berretta, S. (2001). GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology, 25, 1-27.
10. Bliss, T. V., & Lomo, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. Journal of Physiology, 232, 331-356.
11. Bourgeois, J. P., Goldman-Rakic, P. S., & Rakic, P. (1994). Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cerebral Cortex, 4, 78-96.
12. Cardno, A. G., Sham, P. C., Murray, R. M., & McGuffin, P. (2001). Twin study of symptom dimensions in psychosis. British Journal of Psychiatry, 179, 39-45.
13. Carter, C. S., Braver, T. S., Barch, D. M., Botvinick, M., Noll, D., & Cohen, J. D. (1998). Anterior cingulate cortex, error detection, and the on line monitoring of performance. Science, 280, 747-749.
14. Chapman, L. J., & Chapman, J. P. (1973). Problems in the measurement of cognitive deficit. Psychological Bulletin, 79, 380-385.
15. Chowdari, K. V., Mirnics, K., Semwal, P., Wood, J., Lawrence, E., Bhatia, T., et al. (2002). Association and linkage analyses of rgs4 polymorphisms in schizophrenia. Human Molecular Genetics, 11, 1373-1380.
16. Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., et al. (2002). Genetic and physiological data implicating the new human gene g72 and the gene for d-amino acid oxidase in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 99, 13675-13680.
17. Cicchetti, D., & Blender, J. A. (2004). A multiple-levels-of-analysis approach to the study of developmental processes in maltreated children. Proceedings of the National Academy of Science of the United States of America, 101, 17316-17321.
18. Cicchetti, D., & Blender, J. A. (in press). A multiple-levels-of-analysis perspective on resilience: Implications for the developing brain, neuroplasticity and preventative interventions. Annals of the New York Academy of Sciences.
19. Cicchetti, D., & Cannon, T. D. (1999). Neurodevelopmental processes in the ontogenesis and epigenesis of psychopathology. Developmental Psychopathology, 11, 375-393.
20. Cicchetti, D., & Rogosch, F. A. (2002). A developmental psychopathology perspective on adolescence. Journal of Consulting and Clinical Psychology, 70, 6-20.
21. Cohen, J. D., Barch, D. M., Carter, C. S., & Servan-Schreiber, D. (1999). Context-processing deficits in schizophrenia: Converging evidence from three theoretically motivated cognitive tasks. Journal of Abnormal Psychology, 108, 120-133.
22. Cohen, J. D. & Servan-Schreiber, D. (1992). Context, cortex and dopamine: A connectionist approach to behavior and biology in schizophrenia. Psychological Review, 99, 45-77.
23. Coyle, J. T., & Tsai, G. (2004). The NMDA receptor glycine modulatory site: A therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berlin), 174, 32-38.
24. Crow, T. J. (1980). Molecular pathology of schizophrenia: More than one dimension of pathology? British Medical Journal, 280, 66-68.
25. Davison, L. A. (1974). Current status of clinical neuropsychology. In R. M. Reitan & L. A. Davison (Eds.), Clinical neuropsychology: Current status and applications (pp. 211-236). Washington, DC: Wiley.
26. Devlin, B., Bacanu, S. A., Roeder, K., Reimherr, F., Wender, P., Galke, B., et al. (2002). Genome-wide multipoint linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of palau. Molecular Psychiatry, 7, 689-694.
27. Domino, E. F., & Luby, E. D. (1981). Abnormal mental states induced by phencyclidine as a model of schizophrenia. In E. F. Domino (Ed.), PCP (phencyclidine): Historical and current perspectives (pp. 401-418). Ann Arbor, MI: NPP Books.
28. Ebmeier, K. P., Lawrie, S. M., Blackwood, D. H. R., Johnstone, E. C., & Goodwin, G. M. (1995). Hypofrontality revisited: A high resolution single photon emission computer tomography study in schizophrenia. Journal of Neurology, Neurosurgery and Psychiatry, 58, 452-456.
29. Egan, M., Straub, R., Goldberg, T., Yakub, I., Callicott, J., Hariri, A., et al. (2004). Variation in grm3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 101, 12604-12609.
30. Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., et al. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Science of the United States of America, 98, 6917-6922.
31. Fan, J.-B., Zhang, C.-S., Gu, N.-F., Li, X.-W., Sun, W.-W., Wang, H.-Y., et al. (2005). Catechol-o-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis. Biological Psychiatry, 57, 139-144.
32. Friston, K. J., & Frith, C. D. (1995). Schizophrenia: A disconnection syndrome? Clinical Neuroscience, 3, 89-97.
33. Fujii, Y., Shibata, H., Kikuta, R., Makino, C., Tani, A., Hirata, N., et al. (2003). Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (grm3) with schizophrenia. Psychiatric Genetics, 13, 71-76.
34. Gerber, D., Hall, D., Miyakawa, T., Demars, S., Gogos, J., Karayiorgou, M., et al. (2003). Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, ppp3cc, encoding the calcineurin gamma subunit. Proceedings of the National Academy of Sciences of the United States of America, 100, 8993-8998.
35. Glahn, D. C., Ragland, J. D., Adramoff, A., Barrett, J., Laird, A. R., Bearden, C. E., et al. (2005). Beyond hypofrontality: A quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Human Brain Mapping, 25, 60-69.
36. Glantz, L. A., & Lewis, D. A. (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archives of General Psychiatry, 57, 65-73.
37. Gottesman, I. I. (1991). Schizophrenia genesis: The origins of madness. New York: W.H. Freeman.
38. Gottesman, I. I., & Shields, J. (1966). Schizophrenia in twins: 16 years' consecutive admissions to a psychiatric clinic. British Journal of Psychiatry, 112, 809-818.
39. Gur, R. C., & Gur, R. E. (1995). Hypofrontality in schizophrenia: Rip. Lancet, 345, 1338-1340.
40. Hebb, D. O. (1949). The organization of behaviour. New York: Wiley.
41. Heinrichs, R. W. (2005). The primacy of cognition in schizophrenia. American Psychologist, 60, 229-242.
42. Herron, C. E., Lester, R. A., Coan, E. J., & Collingridge, G. L. (1986). Frequency-dependent involvement of nmda receptors in the hippocampus: A novel synaptic mechanism. Nature, 322, 265-268.
43. Hill, K., Mann, L., Laws, K. R., Stephenson, C. M. E., Nimmo-Smith, I., & McKenna, P.J. (2004). Hypofrontality in schizophrenia: A meta-analysis of functional imaging studies. Acta Psychiatricia Scandinavica, 110, 243-256.
44. Hoffman, R. E., & McGlashan, T. H. (1993). Parallel distributed processing and the emergence of schizophrenic symptoms. Schizophrenia Bulletin, 19, 119-140.
45. Hoffman, R. E., & McGlashan, T. H. (1997). Synaptic elimination, neurodevelopment, and the mechanism of hallucinated "voices" in schizophrenia. American Journal of Psychiatry, 154, 1683-1689.
46. Hoffman, R. E., & McGlashan, T. H. (2001). Neural network models of schizophrenia. Neuroscientist, 7, 441-454.
47. Holmes, A. J., MacDonald, A. W. III, Carter, C. S., Barch, D. M., Stenger, V. A., & Cohen, J. D. (2005). Prefrontal functioning during context processing in schizophrenia and major depression: An event-related fMRI study. Schizophrenia Research, 76, 199-206.
48. Huttenlocher, P. R. (1979). Synaptic density in human frontal cortex - Developmental changes and effects of aging. Brain Research, 163, 195-205.
49. Huttenlocher, P. R., & Dabholkar, A. S. (1997). Regional differences in synaptogenesis in human cerebral cortex. Journal of Comparative Neurology, 387, 167-178.
50. Ingvar, D. H., & Franzen, G. (1974). Distribution of cerebral activity in chronic schizophrenia. Lancet, 2, 1484-1486.
51. Javitt, D. C., Jotkowitz, A., Sircar, R., & Zukin, S. R. (1987). Non-competitive regulation of phencyclidine/sigma-receptors by the N-methyl-D-aspartate receptor antagonist d-(-)-2-amino-5-phosphonovaleric acid. Neuroscience Letters, 78, 193-198.
52. Javitt, D. C., & Zukin, S. R. (1991). Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry, 148, 1301-1308.
53. Jentsch, J. D., Redmond, D. E., Jr., Elsworth, J. D., Taylor, J. R., Youngren, K. D., & Roth, R. H. (1997). Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science, 277, 953-955.
54. 18Fluorodeoxyglucose PET in schizophrenia. Psychiatry Research, 16, 317-329.
55. Joyce, E., & Huddy, V. (2004). Defining the cognitive impairment in schizophrenia. Psychological Medicine, 34, 1151-1155.
56. Kety, S. S., Rosenthal, W., Wender, P. H., & Schulsinger, F. (1971). Mental illness in the biological and adoptive families of adopted schizophrenics. American Journal of Psychiatry, 128, 302-306.
57. Kippin, T. E., Kapur, S., & van der Kooy, D. (2005). Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs. Journal of Neuroscience, 25, 5815-5823.
58. Knight, R. (1984). Converging models of cognitive deficits in schizophrenia. In W. Spaulding & J. Coles (Eds.), Nebraska Symposium on Motivation: Theories of schizophrenia and psychosis (Vol. 31, pp. 93-156). Lincoln, NE: University of Nebraska Press.
59. Korostishevsky, M., Kaganovich, M., Cholostoy, A., Ashkenazi, M., Ratner, Y., Dahary, D., et al. (2004). Is the g72/g30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biological Psychiatry, 56, 169-176.
60. Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Bremner, J. D., et al. (1994). Subanesthetic effects of the noncompetitive nmda antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry, 51, 199-214.
61. Laruelle, M., Kegeles, L. S., & Abi-Dargham, A. (2003). Glutamate, dopamine and schizophrenia: From pathophysiology to treatment. Annals of the New York Academy of Sciences, 1003, 138-158.
62. Lewis, D. A. (1997). Development of the prefrontal cortex during adolescence: Insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology, 16, 385-398.
63. Lewis, D. A., Glantz, L. A., Pierri, J. N., & Sweet, R. A. (2003). Altered cortical glutamate neurotransmission in schizophrenia: Evidence from morphological studies of pyramidal neurons. Annals of the New York Academy of Sciences, 1003, 102-112.
64. Lewis, D. A., & Gonzalez-Burgos, G. (2000). Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia. Brain Research Bulletin, 52, 309-317.
65. Liddle, P. F. (1987). Syndromes of chronic schizophrenia: A re-examination of the positive-negative dichotomy. British Journal of Psychiatry, 151, 145-151.
66. Liu, H., Heath, S. C., Sobin, C., Roos, J. L., Galke, B. L., Blundell, M. L., et al. (2002). Genetic variation at the 22q11 prodh2/dgcr6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proceedings of the National Academy of Science of the United States of America, 99, 3717-3722.
67. Loftus, J., DeLisi, L., & Crow, T. (1998). Familial associations of subsyndromes of psychosis in affected sibling pairs with schizophrenia and schizoaffective disorder. Psychiatry Research, 80, 101-111.
68. Logothetis, N. K. (2002). The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal. Philosophical Transactions of the Royal Society of London, Series B, Biological Sciences, 357, 1003-1037.
69. Luisada, P. V. (1978). The phencyclidine psychosis: Phenomenology and treatment. NIDA Research Monograph, 1, 241-253.
70. MacDonald, A. W. III, Becker, T. M., & Carter, C. S. (in press). Functional MRI study of cognitive control in the healthy relatives of schizophrenia patients. Biological Psychiatry.
71. MacDonald, A. W. III, & Carter, C. S. (2002). Cognitive experimental approaches to investigating impaired cognition in schizophrenia: A paradigm shift. Journal of Clinical and Experimental Neuropsychology, 24, 873-882.
72. MacDonald, A. W. III, & Carter, C. S. (2003). Event-related fMRI study of context processing in dorsolateral prefrontal cortex of patients with schizophrenia. Journal of Abnormal Psychology, 112, 689-697.
73. MacDonald, A. W. III, Carter, C. S., Kerns, J. G., Ursu, S., Barch, D. M., Holmes, A., et al. (2005). Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in a never-medicated first-episode sample. American Journal of Psychiatry, 162, 475-484.
74. MacDonald, A. W. III, Goghari, V. M., Hicks, B. M., Flory, J. D., Carter, C. S., & Manuck, S. B. (2005). A convergent-divergent approach to context processing, general intellectual functioning and the genetic liability to schizophrenia. Neuropsychology, 19, 814-821.
75. MacDonald, A. W. III, & Kang, S. S. (in press). Cassandra's calculations: Simulation studies of the psychometric confound. In F. Columbus (Ed.), Schizophrenia psychology: New research. Hauppauge, NY: Nove Science Publishers.
76. MacDonald, A. W. III, Pogue-Geile, M. F., Johnson, M. K., & Carter, C. S. (2003). A specific deficit in context processing in the unaffected siblings of patients with schizophrenia. Archives of General Psychiatry, 60, 57-65.
77. Malinow, R., & Miller, J. P. (1986). Postsynaptic hyperpolarization during conditioning reversibly blocks induction of long-term potentiation. Nature, 320, 529-530.
78. 2+ of NMDA responses in spinal cord neurones. Nature, 309, 261-263.
79. Meehl, P. E. (1962). Schizotaxia, schizotypy, schizophrenia. American Psychologist, 17, 827-838.
80. Millar, J. K., Wilson-Annan, J. C., Anderson, S., Christie, S., Taylor, M. S., Semple, C. A., et al. (2000). Disruption of two novel genes by a translocation co-segregating with schizophrenia. Human Molecular Genetics, 22, 1415-1423.
81. Miller, E. K. (2000). The prefrontal cortex and cognitive control. Nature Reviews, 1, 59-65.
82. Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001). Disease-specific changes in regular of g-protein signaling 4 (rgs4) expression in schizosphrenia. Molecular Psychiatry, 6, 293-301.
83. Moghaddam, B. (2003). Bringing order to the glutamate chaos in schizophrenia. Neuron, 40, 881-884.
84. Moises, H. W., Zoega, T., & Gottesman, II. (2002). The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry, 2, 8.
85. Numakawa, T., Yagasaki, Y., Ishimoto, T., Okada, T., Suzuki, T., Iwata, N., et al. (2004). Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Human Molecular Genetics, 13, 2699-2708.
86. O'Donnell, P., Lewis, B. L., Weinberger, D. R., & Lipska, B. K. (2002). Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cerebral Cortex, 12, 975-982.
87. Ogawa, S., Lee, T. M., Kay, A. R., & Tank, D. W. (1990). Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proceedings of the National Academy of Sciences of the United States of America, 87, 9868-9872.
88. Owen, M. J., Williams, N. M., & O'Donovan, M. C. (2004). The molecular genetics of schizophrenia: New findings promise new insights. Molecular Psychiatry, 9, 14-27.
89. Peralta, V., & Cuesta, M. (1999). Dimensional structure of psychotic symptoms: An item-level analysis of saps and sans symptoms in psychotic disorders. Schizophrenia Research, 38, 13-26.
90. Perlstein, W. M., Dixit, N. K., Carter, C. S., Noll, D. C., & Cohen, J. D. (2003). Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biological Psychiatry, 53, 25-38.
91. Phillips, W. A., & Silverstein, S. M. (2003). Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia. Behavioral and Brain Sciences, 26, 65-138.
92. Pierri, J. N., Chaudry, A. S., Woo, T. U., & Lewis, D. A. (1999). Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. American Journal Psychiatry, 156, 1709-1719.
93. Plum, F. (1972). Prospects for research on schizophrenia. 3. Neuropsychology. Neuropathological findings. Neurosciences Research Program Bulletin, 10, 384-388.
94. Rakic, P., Bourgeois, J. P., Eckenhoff, M. F., Zecevic, N., & Goldman-Rakic, P. S. (1986). Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science, 232, 232-235.
95. Rice, S., Niu, N., Berman, D., Heston, L., & Sobell, J. (2001). Identification of single nucleotide polymorphisms (snps) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the nmdar1 receptor gene in schizophrenic patients. Molecular Psychiatry, 6, 274-284.
96. Rosvold, K. E., Mirsky, A. F., Sarason, I., Bransome, E. D., & Beck, L. H. (1956). A continuous performance test of brain damage. Journal of Consulting Psychology, 20, 343-350.
97. Rudin, E. (Ed.). (1916). Studien über vererbung und entstehung geistiger störungen. I. Zur vererbung und neuentstehung der dementia praecox. [Studies on the inheritance and origin of mental illness. I. The problem of the inheritance and primary origin of Dementia praecox] (Vol. 12). Berlin: Springer.
98. Selemon, L. D., & Goldman-Rakic, P. S. (1999). The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biological Psychiatry, 45, 17-25.
99. Selemon, L. D., Kleinman, J. E., Herman, M. M., & Goldman-Rakic, P. S. (2002). Smaller frontal gray matter volume in postmortem schizophrenic brains. American Journal of Psychiatry, 159, 1983-1991.
100. Selemon, L. D., Rajkowska, G., & Goldman-Rakic, P. S. (1995). Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Archives of General Psychiatry, 52, 805-818; discussion 819-820.
101. Servan-Schreiber, D., Cohen, J., & Steingard, S. (1996). Schizophrenic deficits in the processing of context: A test of a theoretical model. Archives of General Psychiatry, 53, 1105-1112.
102. Shi, S. H., Hayashi, Y., Petralia, R. S., Zaman, S. H., Wenthold, R. J., Svoboda, K., et al. (1999). Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science, 284, 1811-1816.
103. Shifman, S., Bronstein, M., Siante-Shalom, A., Lev-Lehman, E., Weizman, A., Reznik, I. et al. (2002). A high selective association between a COMT haplotype and schizophrenia. American Journal of Human Genetics, 72, 1296-1302.
104. Simon, J. R. (1990). The effects of an irrelevant directional cue on human information processing. In R. W. Proctor & T. G. Reeve (Eds.), Stimulus-response compatibility: An integrated perspective (pp. 31-86). Amsterdam: North-Holland.
105. Stefani, M. R., & Moghaddam, B. (2005). Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats. Behavioral Neuroscience, 119, 420-428.
106. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics, 71, 877-892.
107. Stephan, K. E., Baldeweg, T., & Friston, K. J. (2006). Synaptic plasticity and dysconnection in schizophrenia. Biological Psychiatry, 59, 929-939.
108. Stoet, G., & Snyder, L. H. (2005). Effects of the NMDA antagonist ketamine on task-switching performance: Evidence for specific impairments of executive control. Neuropsychopharmacology [Advance online publication, doi: 10.1038/sj.npp.1300930].
109. Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., et al. (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. American Journal of Human Genetics, 71, 337-348.
110. Strauss, M. E. (2001). Demonstrating specific cognitive deficits: A psychometric perspective. Journal of Abnormal Psychology, 110, 6-14.
111. Thune, J. J., Uylings, H. B., & Pakkenberg, B. (2001). No deficit in total number of neurons in the prefrontal cortex in schizophrenics. Journal of Psychiatric Research, 35, 15-21.
112. Toyooka, K., Muratake, T., Tanaka, T., Igarashi, S., Watanabe, H., Takeuchi, H., et al. (1999). 14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia. American Journal of Medical Genetics, 88, 164-167.
113. Vawter, M., Crook, J., Hyde, T., Kleinman, J. E., Weinberger, D., Becker, K., et al. (2002). Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: A preliminary study. Schizophrenia Research, 58, 11-20.
114. Weickert, C. S., Straub, R. E., McClintock, B. W., Matsumoto, M., Hashimoto, R., Hyde, T. M., et al. (2004). Human dysbindin (dtnbp1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Archives of General Psychiatry, 61, 544-555.
115. Weinberger, D. R., Berman, K., & Zec, R. (1986). Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia I. Regional cerebral bloodflow evidence. Archives of General Psychiatry, 43, 114-124.
116. Woo, T. U., Pucak, M. L., Kye, C. H., Matus, C. V., & Lewis, D. A. (1997). Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex. Neuroscience, 80, 1149-1158.